Current and potential treatments for primary Sjögren’s syndrome

This publication has 9 references indexed in Scilit:

• Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group
  Annals of the Rheumatic Diseases, 2002
• Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells
  Annals of the Rheumatic Diseases, 2001
• Infliximab in patients with primary Sjögren's syndrome: A pilot study
  Arthritis & Rheumatism, 2001
• Suppression of tumor necrosis factor α-induced matrix metalloproteinase 9 production by the introduction of a super-repressor form of inhibitor of nuclear factor κBα complementary DNA into immortalized human salivary gland acinar cells: Prevention of the destruction of the acinar structure in Sjögren's syndrome salivary glands
  Arthritis & Rheumatism, 2000
• Pilocarpine Tablets for the Treatment of Dry Mouth and Dry Eye Symptoms in Patients With Sjögren SyndromeA Randomized, Placebo-Controlled, Fixed-Dose, Multicenter Trial
  Archives of internal medicine (1960), 1999
• Lymphomas in Patients With Sjögren's Syndrome Are Marginal Zone B-Cell Neoplasms, Arise in Diverse Extranodal and Nodal Sites, and Are Not Associated With Viruses
  Blood, 1997
• Respiratory function in systemic lupus erythematosus: relation with activity and severity
  Lupus, 1996
• Hydroxychloroquine treatment for primary Sjögren’s syndrome: a two year double blind crossover trial.
  Annals of the Rheumatic Diseases, 1993
• Treatment of primary Sjögren's syndrome with hydroxychloroquine
  The American Journal of Medicine, 1988